Aurobindo Pharma Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹1533.4Market Cap
₹ 89,060 Cr.Stock P/E
25.1ROE
10.1 %RSI
61.93Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)
Aurobindo Pharma Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Aurobindo Pharma Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Aurobindo Pharma Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 1533.4 |
| RSI (14) | 61.93 |
| 50 DMA | 1501.76 |
| 200 DMA | 1290.46 |
| Trend | Bullish |
| A/D Rating | C |
| RS Rating | 84 |
| EPS Rating | 31 |
| TI65 | 1.05 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Aurobindo Pharma Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹1583.8 |
| R2 | ₹1574.4 |
| R1 | ₹1561.4 |
| PP | ₹1552 |
| S1 | ₹1539 |
| S2 | ₹1529.6 |
| S3 | ₹1516.6 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 89,060 Cr. |
| Current Price | ₹ 1,533 |
| High / Low | ₹ 1,637 / 1,016 |
| Stock P/E | 25.1 |
| Book Value | ₹ 652 |
| Dividend Yield | 0.26 % |
| ROCE | 12.8 % |
| ROE | 10.1 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 6,473 | 506 | 15% |
| Jun 2023 | 6,851 | 570 | 17% |
| Sep 2023 | 7,219 | 752 | 19% |
| Dec 2023 | 7,352 | 940 | 22% |
| Mar 2024 | 7,580 | 907 | 22% |
| Jun 2024 | 7,567 | 918 | 21% |
| Sep 2024 | 7,796 | 817 | 20% |
| Dec 2024 | 7,979 | 846 | 20% |
| Mar 2025 | 8,382 | 903 | 21% |
| Jun 2025 | 7,868 | 824 | 20% |
| Sep 2025 | 8,286 | 848 | 20% |
| Dec 2025 | 8,646 | 910 | 21% |
| Mar 2026 | 8,853 | 921 | 20% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 51.87% |
| FIIs | 20.99% |
| DIIs | 12.76% |
| Government | 0.00% |
| Public | 14.38% |
| No. of Shareholders | 1,91,317 |
Pros and Cons
Pros
- Strong technical momentum with price holding comfortably above the 50 DMA (1501.76).
- Outperforming over 70% of the entire market universe over the past 12 months.
Cons
Related NSE Stocks
Five-Star Business Finance Limited
View Share Price Analysis →CCL Products (India) Limited
View Share Price Analysis →Godfrey Phillips India Limited
View Share Price Analysis →HDFC Bank Limited
View Share Price Analysis →Indus Towers Limited
View Share Price Analysis →KEC International Limited
View Share Price Analysis →Transformers And Rectifiers (India) Limited
View Share Price Analysis →Zee Entertainment Enterprises Limited
View Share Price Analysis →Apollo Hospitals Enterprise Limited
View Share Price Analysis →Gillette India Limited
View Share Price Analysis →Grasim Industries Limited
View Share Price Analysis →Latent View Analytics Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Aurobindo Pharma Ltd share?
Based on the latest closing data, the technical momentum for Aurobindo Pharma Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 61.93, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (1501.76) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Aurobindo Pharma Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Aurobindo Pharma Ltd today centers at a Pivot Point (PP) of ₹1552. Upside resistance challenges are calculated at R1: ₹1561.4, R2: ₹1574.4, and R3: ₹1583.8. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹1539, S2: ₹1529.6, and S3: ₹1516.6.
How does the fundamental ROE and P/E ratio look for Aurobindo Pharma Ltd?
Aurobindo Pharma Ltd is currently trading with a valuation metrics context of a Stock P/E of 25.1, against a core structural efficiency Return on Equity (ROE) standing at 10.1 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 31, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Aurobindo Pharma Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Aurobindo Pharma Ltd is trading abo... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of C, a Relative Strength (RS) ranking of 84, and long-term trend backing from the TI65 indicator (Neutral pattern).